United States Bisphosphonate Drugs Market Research Report Forecast 2017-2022

July 2017 | 112 pages | ID: U21289A6008EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The United States Bisphosphonate Drugs Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Bisphosphonate Drugs industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Bisphosphonate Drugs market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:

Pfizer Inc. (USA)
Abbott Laboratories (USA)
Merck & Co., Inc. (US)
GlaxoSmithKline Plc (UK)
Sanofi SA (France)
Indevus Pharmaceuticals Inc. (USA)
Decartis AG (Switzerland)
OSI Pharmaceuticals, Inc. (USA)
Paladin Labs Inc. (Canada)

United States Bisphosphonate Drugs Market: Product Segment Analysis

• Type 1
• Type 2
• Type 3

United States Bisphosphonate Drugs Market: Application Segment Analysis

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 BISPHOSPHONATE DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Bisphosphonate Drugs
1.2 Bisphosphonate Drugs Market Segmentation by Type
  1.2.1 United States Production Market Share of Bisphosphonate Drugs by Type in 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Bisphosphonate Drugs Market Segmentation by Application
  1.3.1 Bisphosphonate Drugs Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Bisphosphonate Drugs (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON BISPHOSPHONATE DRUGS INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES BISPHOSPHONATE DRUGS MARKET COMPETITION BY MANUFACTURERS

3.1 United States Bisphosphonate Drugs Production and Share by Manufacturers (2015 and 2016)
3.2 United States Bisphosphonate Drugs Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Bisphosphonate Drugs Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Bisphosphonate Drugs Manufacturing Base Distribution, Production Area and Product Type
3.5 Bisphosphonate Drugs Market Competitive Situation and Trends
  3.5.1 Bisphosphonate Drugs Market Concentration Rate
  3.5.2 Bisphosphonate Drugs Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES BISPHOSPHONATE DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Bisphosphonate Drugs Production and Market Share by Type (2012-2017)
4.2 United States Bisphosphonate Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Bisphosphonate Drugs Price by Type (2012-2017)
4.4 United States Bisphosphonate Drugs Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES BISPHOSPHONATE DRUGS MARKET ANALYSIS BY APPLICATION

5.1 United States Bisphosphonate Drugs Consumption and Market Share by Application (2012-2017)
5.2 United States Bisphosphonate Drugs Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES BISPHOSPHONATE DRUGS MANUFACTURERS ANALYSIS

6.1 Pfizer Inc. (USA)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 Abbott Laboratories (USA)
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Merck & Co., Inc. (US)
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 GlaxoSmithKline Plc (UK)
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Sanofi SA (France)
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Indevus Pharmaceuticals Inc. (USA)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Decartis AG (Switzerland)
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 OSI Pharmaceuticals, Inc. (USA)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 Paladin Labs Inc. (Canada)
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 BISPHOSPHONATE DRUGS MANUFACTURING COST ANALYSIS

7.1 Bisphosphonate Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Bisphosphonate Drugs

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Bisphosphonate Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Bisphosphonate Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES BISPHOSPHONATE DRUGS MARKET FORECAST (2017-2022)

11.1 United States Bisphosphonate Drugs Production, Revenue Forecast (2017-2022)
11.2 United States Bisphosphonate Drugs Production, Consumption Forecast by Regions (2017-2022)
11.3 United States Bisphosphonate Drugs Production Forecast by Type (2017-2022)
11.4 United States Bisphosphonate Drugs Consumption Forecast by Application (2017-2022)
11.5 Bisphosphonate Drugs Price Forecast (2017-2022)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Bisphosphonate Drugs
Table Classification of Bisphosphonate Drugs
Figure United States Sales Market Share of Bisphosphonate Drugs by Type in 2016
Table Application of Bisphosphonate Drugs
Figure United States Sales Market Share of Bisphosphonate Drugs by Application in 2016
Figure United States Bisphosphonate Drugs Sales and Growth Rate (2011-2021)
Figure United States Bisphosphonate Drugs Revenue and Growth Rate (2011-2021)
Table United States Bisphosphonate Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Bisphosphonate Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Bisphosphonate Drugs Sales Share by Manufacturers
Figure 2016 Bisphosphonate Drugs Sales Share by Manufacturers
Table United States Bisphosphonate Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Bisphosphonate Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Bisphosphonate Drugs Revenue Share by Manufacturers
Table 2016 United States Bisphosphonate Drugs Revenue Share by Manufacturers
Table United States Market Bisphosphonate Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Bisphosphonate Drugs Average Price of Key Manufacturers in 2015
Figure Bisphosphonate Drugs Market Share of Top 3 Manufacturers
Figure Bisphosphonate Drugs Market Share of Top 5 Manufacturers
Table United States Bisphosphonate Drugs Sales by Type (2012-2017)
Table United States Bisphosphonate Drugs Sales Share by Type (2012-2017)
Figure United States Bisphosphonate Drugs Sales Market Share by Type in 2015
Table United States Bisphosphonate Drugs Revenue and Market Share by Type (2012-2017)
Table United States Bisphosphonate Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Bisphosphonate Drugs by Type (2012-2017)
Table United States Bisphosphonate Drugs Price by Type (2012-2017)
Figure United States Bisphosphonate Drugs Sales Growth Rate by Type (2012-2017)
Table United States Bisphosphonate Drugs Sales by Application (2012-2017)
Table United States Bisphosphonate Drugs Sales Market Share by Application (2012-2017)
Figure United States Bisphosphonate Drugs Sales Market Share by Application in 2016
Table United States Bisphosphonate Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Bisphosphonate Drugs Sales Growth Rate by Application (2012-2017)
Table Pfizer Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Inc. (USA) Bisphosphonate Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Inc. (USA) Bisphosphonate Drugs Market Share (2012-2017)
Table Abbott Laboratories (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Abbott Laboratories (USA) Bisphosphonate Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Laboratories (USA) Bisphosphonate Drugs Market Share (2012-2017)
Table Merck & Co., Inc. (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Merck & Co., Inc. (US) Bisphosphonate Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Merck & Co., Inc. (US) Bisphosphonate Drugs Market Share (2012-2017)
Table GlaxoSmithKline Plc (UK) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Plc (UK) Bisphosphonate Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Plc (UK) Bisphosphonate Drugs Market Share (2012-2017)
Table Sanofi SA (France) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Sanofi SA (France) Bisphosphonate Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi SA (France) Bisphosphonate Drugs Market Share (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Indevus Pharmaceuticals Inc. (USA) Bisphosphonate Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Bisphosphonate Drugs Market Share (2012-2017)
Table Decartis AG (Switzerland) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Decartis AG (Switzerland) Bisphosphonate Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Decartis AG (Switzerland) Bisphosphonate Drugs Market Share (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table OSI Pharmaceuticals, Inc. (USA) Bisphosphonate Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Bisphosphonate Drugs Market Share (2012-2017)
Table Paladin Labs Inc. (Canada) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Paladin Labs Inc. (Canada) Bisphosphonate Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Paladin Labs Inc. (Canada) Bisphosphonate Drugs Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bisphosphonate Drugs
Figure Manufacturing Process Analysis of Bisphosphonate Drugs
Figure Bisphosphonate Drugs Industrial Chain Analysis
Table Raw Materials Sources of Bisphosphonate Drugs Major Manufacturers in 2016
Table Major Buyers of Bisphosphonate Drugs
Table Distributors/Traders List
Figure United States Bisphosphonate Drugs Production and Growth Rate Forecast (2017-2022)
Figure United States Bisphosphonate Drugs Revenue and Growth Rate Forecast (2017-2022)
Table United States Bisphosphonate Drugs Production Forecast by Type (2017-2022)
Table United States Bisphosphonate Drugs Consumption Forecast by Application (2017-2022)